Advertisement · 728 × 90

Posts by Dr.B

Preview
The Top 10 Nations Redrawing the Outsourcing Map There was a time when your outsourcing strategy could be managed with a simple spreadsheet and a focus on cost-per-liter. Those days are gone…

New List!
Global outsourcing is shifting from low-cost volume to resilience and high-tech value. Is your network ready for the new geography of drug development? #Pharma #CDMO #Biotech #Top10List

4 months ago 1 0 0 0
Preview
How AI Is Rewriting Tech Transfer Timelines By replacing trial-and-error with virtual simulations and predictive analytics, AI is giving even small biotechs the process development capabilities once reserved for Big Pharma—and slashing tech transfer timelines in the process.

Hope everyone had a great holiday! Here's my latest piece. #ai #pharma #outsourcing #techtransfer

4 months ago 3 0 0 0
Preview
The 9 Fastest-Growing Outsourcing Segments Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.

📈 Outsourcing in #biopharma is booming. Fastest-growing areas: cell & gene therapy, viral vectors, peptides, and ADCs. Capability—not capacity—is the real bottleneck.
#CDMO #pharma #cgt #adc

5 months ago 1 0 0 0
Preview
Cell & Gene Therapy Outsourcing's New Paradigm The industry has flipped from scarcity to surplus, and sponsors now have leverage to set terms, not take numbers.

CGT flipped from scarcity theater to a buyer’s market. Act like a customer—own your process, demand method portability and raw-data access, shape MSAs/SLAs around cycle time. Build only if utilization holds ≥70–80%
#Outsourcing #CGT #Bioprocessing #CMC

6 months ago 1 0 0 0
Preview
Clear The Outsourcing Runway: The 8 Largest Deals In The Past Year We ranked the past year’s eight biggest pharma–CDMO manufacturing deals and decoded what they signal for your next outsourcing project.

My latest list!
#Pharma #Biotech #Outsourcing #CDMO #Biopharma

6 months ago 2 0 0 0
Preview
Green Is The New KPI: Sustainability In Pharma Outsourcing Sustainability is moving from marketing to metering, as sponsors look for facility-level metrics and contract incentives that drive measurable improvement.

My inaugural feature for Outsourced Pharma! Green is the new KPI in pharma outsourcing. Sponsors are now asking CDMOs for facility-level energy, waste, and cold-chain data.

7 months ago 2 0 0 0